ANCA-associated life-threatening systemic vasculitis after alemtuzumab treatment for multiple sclerosis

Multiple Sclerosis

Serum sickness (Like Reaction) in a patient treated with alemtuzumab for multiple sclerosis: A case report

Mult Scler Relat Disord.

Lapucci C, Gualandi F, Mikulska M, Palmeri S, Mancardi G, Uccelli A, Laroni A

doi: 10.1016/j.msard.2018.09.006.

Multiple Sclerosis

Acute sarcoidosis in a multiple sclerosis patient after alemtuzumab treatment

Mult Scler.

Graf J, Ringelstein M, Lepka K, Schaller J, Quack H, Hartung HP, Aktas O, Albrecht P

doi: 10.1177/1352458518771276.

Multiple Sclerosis

Neutropenia in Patients With Multiple Sclerosis Treated With Alemtuzumab

JAMA Neurol.

Gaitán MI, Ysrraelit MC, Correale J

doi: 10.1001/jamaneurol.

Multiple Sclerosis

Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases

Mult Scler.

Boffa G, Sbragia E, Raiola AM, Varaldo R, Capello E, Gallo P, Granella F, Mancardi G, Inglese M

doi: 10.1177/1352458520914818.

Multiple Sclerosis

Early predictors of rapidly evolving multiple sclerosis: A case report

J Neuroimmunol.

Fernando KTM, James M

doi: 10.1016/

Multiple Sclerosis

An Unusual Case of Simultaneous Bilateral Trigeminal Neuralgia Due to Multiple Sclerosis

J Oral Facial Pain Headache.

Di Stefano G, Tinelli E, Truini A

doi: 10.11607/ofph.1831.

Multiple Sclerosis

Secukinumab for patients with plaque psoriasis affected by multiple sclerosis. A mini-review with a representative case report

J Eur Acad Dermatol Venereol.

Venturini M, Zanca A, Venturuzzo A, Filippini M, Frassi M, Tincani A, Calzavara-Pinton PG

doi: 10.1111/jdv.16035.

Multiple Sclerosis

Cryptococcal meningoencephalitis in an IgG₂-deficient patient with multiple sclerosis on fingolimod therapy for more than five years - case report

BMC Neurol.

Wienemann T, Müller AK, MacKenzie C, Bielor C, Weyers V, Aktas O, Hartung HP, Kremer D

doi: 10.1186/s12883-020-01741-0.

Multiple Sclerosis

Efficacy of Natalizumab in Intermediate Uveitis Related to Multiple Sclerosis: A Case Report

doi: 10.1055/s-0043-124756.

Related content

Serum sickness (Like Reaction) in a patient treated with alemtuzumab for multiple sclerosis: A case report

Acute sarcoidosis in a multiple sclerosis patient after alemtuzumab treatment

Neutropenia in Patients With Multiple Sclerosis Treated With Alemtuzumab

Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases

Early predictors of rapidly evolving multiple sclerosis: A case report

An Unusual Case of Simultaneous Bilateral Trigeminal Neuralgia Due to Multiple Sclerosis

Secukinumab for patients with plaque psoriasis affected by multiple sclerosis. A mini-review with a representative case report

Cryptococcal meningoencephalitis in an IgG2-deficient patient with multiple sclerosis on fingolimod therapy for more than five years - case report

Efficacy of Natalizumab in Intermediate Uveitis Related to Multiple Sclerosis: A Case Report

Cryptococcal meningoencephalitis in an IgG₂-deficient patient with multiple sclerosis on fingolimod therapy for more than five years - case report